Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

APA BIPOLAR DISORDER GUIDELINE LISTS LITHIUM AS FIRST CHOICE

Executive Summary

APA BIPOLAR DISORDER GUIDELINE LISTS LITHIUM AS FIRST CHOICE line of therapy, but notes that the newer drugs valproic acid and carbamazapine are also good first choices of treatment, depending on the patient. The American Psychiatric Association, which released its first guideline "for the treatment of patients who have had at least one episode of mania (i.e. Bipolar I Disorder)," said at a Dec. 7 press conference that the guidelines are designed to help psychiatrists diagnose and treat the disease, also known as manic-depressive illness. Bipolar Disorder occurs in approximately 3 mil. American adults, or 1.6% of the U.S. population, according to a recent National Depressive & Manic Depressive Association survey.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS025427

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel